期刊
JOURNAL OF CLINICAL MEDICINE
卷 10, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/jcm10071431
关键词
JAK inhibitor; proliferation; DNA damage repair; γ H2AX; PBMCs; T lymphocytes
资金
- European Union Program Regional Development Fund of the Ministry of Economy, Science and Digitalisation in Saxony-Anhalt
JAKis present a new strategy in rheumatoid arthritis therapy, with similar inhibitory effects on lymphocyte proliferation but potential detrimental effects on cell viability and DNA damage repair at high doses. The study provides insights into the immunomodulatory effects of different JAKis and their impact on PBMCs.
Janus kinase inhibitors (JAKis) represent a new strategy in rheumatoid arthritis (RA) therapy. Still, data directly comparing different JAKis are rare. In the present in vitro study, we investigated the immunomodulatory potential of four JAKis (tofacitinib, baricitinib, upadacitinib, and filgotinib) currently approved for RA treatment by the European Medicines Agency. Increasing concentrations of JAKi or methotrexate, conventionally used in RA therapy, were either added to freshly mitogen-stimulated or preactivated peripheral blood mononuclear cells (PBMC), isolated from healthy volunteers. A comparable, dose-dependent inhibition of lymphocyte proliferation was observed in samples treated with tofacitinib, baricitinib, and upadacitinib, while dosage of filgotinib had to be two orders of magnitude higher. In contrast, antiproliferative effects were strongly attenuated when JAKi were added to preactivated PBMCs. High dosage of upadacitinib and filgotinib also affected cell viability. Further, analyses of DNA double-strand break markers gamma H2AX and 53BP1 indicated an enhanced level of DNA damage in cells incubated with high concentrations of filgotinib and a dose-dependent reduction in clearance of radiation-induced gamma H2AX foci in the presence of tofacitinib or baricitinib. Thereby, our study demonstrated a broad comparability of immunomodulatory effects induced by different JAKi and provided first indications, that (pan)JAKi may impair DNA damage repair in irradiated PBMCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据